{"id":245907,"date":"2012-03-15T15:14:21","date_gmt":"2012-03-15T15:14:21","guid":{"rendered":"http:\/\/www.eugenesis.com\/amedisys-scores-19-above-national-average-on-treatment-goals-met-at-home\/"},"modified":"2012-03-15T15:14:21","modified_gmt":"2012-03-15T15:14:21","slug":"amedisys-scores-19-above-national-average-on-treatment-goals-met-at-home","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/amedisys-scores-19-above-national-average-on-treatment-goals-met-at-home.php","title":{"rendered":"Amedisys Scores 19% Above National Average on Treatment Goals Met at Home"},"content":{"rendered":"<p><p>    BATON ROUGE, La.--(BUSINESS WIRE)--  <\/p>\n<p>    Amedisys,    Inc. (NASDAQ:     AMED -     News) today announced it has proven clinical excellence    with its Speech-Language Pathology (SLP) program, according to    the American    Speech-Language and Hearing Association (ASHA) National    Outcomes Measurement System (NOMS) report for 2011.  <\/p>\n<p>    Developed to illustrate the value of speech-language pathology    services provided to people with swallowing disorders,    cognitive and memory impairments, and communication disorders,    NOMS is a    data collection system, recognized by the Centers for Medicare    and Medicaid Services (CMS). The key to NOMS is the use of    ASHAs Functional Communication Measures (FCMs). FCMs are a    series of disorder-specific seven-point rating scales, designed    to describe the change in an individuals functional    communication, swallowing, or cognitive\/memory abilities over    the course of treatment.  <\/p>\n<p>    According to the 2011 NOMS data, Amedisys Speech-Language    Pathology outcomes for treatment goals met in the home exceeded    the national home care industry average by 19%. The national    average for 2011 was 51.78% of treatment goals met in the home,    while Amedisys met 70.87% of treatment goals.  <\/p>\n<p>    We are extremely proud of our Speech-Language Pathology team    here at Amedisys for achieving this level of high-quality care    for our patients, said Jim Robinson, executive vice president    of home health and hospice care for Amedisys. Our team of 600    speech-language pathologists, based in more than 300 Amedisys    care centers across the country, work with thousands of    patients each year to improve their communication skills and    help with memory deficits. This specialized care often reduces    the need for feeding tubes and helps patients recover the    ability to swallow.  <\/p>\n<p>    Swallowing    disorders (also known as dysphagia) are diagnosed in    approximately 10 million Americans each year. Nearly all    dementia patients develop dysphagia, and swallowing disorders    also are associated with stroke, respiratory conditions, brain    and spinal cord injury, as well as progressive neurological    conditions like multiple sclerosis, ALS and Parkinsons. People    who suffer from swallowing disorders often experience weight    loss, poor nutrition, dehydration, social isolation, choking    and pneumonia.  <\/p>\n<p>    In the last 10 years, the number of elderly Medicare    beneficiaries who were admitted to the hospital for aspiration    pneumonia increased by 93.8%, said David Hutchings,    CCC-SLP.D., managing director of Rehab Services at Amedisys.    Through our Speech Language Pathology program, our    multidisciplinary care team takes a comprehensive approach in    addressing dysphagia to help decrease the risk of aspiration    pneumonia and hospitalizations for this condition.  <\/p>\n<p>    To help those with swallowing disorders avoid health    complications like pneumonia, Dr. Hutchings urges seniors and    their loved ones to watch for, and talk to a health care    professional about, the following symptoms:  <\/p>\n<p>    By proactively treating swallowing disorders and using    specialized feeding techniques that maintain nutritional needs,    enhance safe food intake and maintain dignity for those on our    home health and hospice service, we can help to reduce    unnecessary hospitalizations, and improve peoples overall    quality of life, Dr. Hutchings said.  <\/p>\n<p>    For more information about NOMS, please visit:     <a href=\"http:\/\/www.asha.org\/members\/research\/noms\/\" rel=\"nofollow\">http:\/\/www.asha.org\/members\/research\/noms\/<\/a>.  <\/p>\n<\/p>\n<p>More here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/amedisys-scores-19-above-national-110000628.html\" title=\"Amedisys Scores 19% Above National Average on Treatment Goals Met at Home\">Amedisys Scores 19% Above National Average on Treatment Goals Met at Home<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> BATON ROUGE, La.--(BUSINESS WIRE)-- Amedisys, Inc.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/amedisys-scores-19-above-national-average-on-treatment-goals-met-at-home.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577487],"tags":[],"class_list":["post-245907","post","type-post","status-publish","format-standard","hentry","category-pathology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/245907"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=245907"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/245907\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=245907"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=245907"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=245907"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}